Market Forecast by Countries (United States, Canada), By Infection Type (Skin Infections, ENT (Ear, Nose & Throat) Infections, Stomach Infections, Lungs Infections, Urinary tract infections (UTI), Pneumonia, Bronchitis, Gonorrhea), By Route of Administration (Oral, Intravenous), By Form (Tablets, Capsule, Suspensions, Syrup, Powder), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) And Competitive Landscape
| Product Code: ETC075604 | Publication Date: Aug 2021 | Updated Date: Apr 2023 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
North America Amoxicillin Market report thoroughly covers the market by country, by infection type, by route of administration, by form, and by distribution channel. The market outlook report provides an unbiased and detailed analysis of the ongoing Market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
The North America Amoxicillin Market is projected to grow in the forecast year. Amoxicillin is crucial in medical treatment. It is also the most prescribed antibiotic. Due to the rise in infectious diseases, there is an increase in demand for medications. Infectious diseases are one of the major health problems prevalent in the world and availability of the Amoxicillin is providing different options for treatment.
According to 6Wresearch, the North America Amoxicillin Market size is projected to grow during 2021-2027. Amoxicillin is used in the treatment of infections caused by bacteria. The market is primarily driven by the rise in the number of infectious diseases and the growing trend of self-medication and surgeries. The infections in bronchitis, pneumonia, and ear can be treated through Amoxicillin. The antibiotic is also effective against skin disease and sexually transmitted diseases. Amoxicillin is available in different forms such as powder, tablets, and injectables. The drug can also be consumed orally and by injection. The government is also taking various measures to boost the sector by investing in public health programs, accelerating the growth of the market. There are various challenges faced by the market. Due to regulations by the government, the amoxicillin market is currently under review. This has led to a decline in sales. There is an availability of other medications in the market leading to a decline in the North America Amoxicillin Market Growth.
The coronavirus pandemic affected the growth of a number of sectors across the world and the North America Amoxicillin Industry was no exception. Due to the increase in a number of sick individuals, there was a rise in demand for Amoxicillin. Due to the sudden outbreak of the pandemic, suppliers found it difficult to keep up with the demand. There was a delay in production and shipping and the supply chain was also disturbed. There was a change in prescribing patterns due to the pandemic and the doctors were reluctant to provide antibiotics. This led to the decline in North America Amoxicillin Market Share.
The notable players in the market are Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A, and Merck & Co Inc. These companies have a strong position in the market and the competition is high among all these major players. To overcome the challenges of the market, these companies are launching new products and expanding their business. These companies are also expanding their product portfolios to attain the top position in the market.
On the basis of countries the market is segmented into the United States, and Canada. The United States is the largest industry for amoxicillin. The United States market is witnessing growth due to increasing in bacterial infections. Canada is expanding significantly due to medicine being available in the market in different formulations.
On The Basis of infection, the market is segmented into Skin Infections, ENT (Ear, Nose & Throat) Infections, Stomach Infections, Lungs Infections, Urinary Tract Infections (UTI), Pneumonia, Bronchitis, and Gonorrhoea. Amoxicillin is widely used in treatment of skin infections. In ENT (Ear, Nose, and Throat) infections, the drug is prescribed to kill bacteria so the body can heal . Stomach infection can also be treated by amoxicillin. Other medicines and amoxicillin is combined to remove stomach ulcers. Lung infections are treated with amoxicillin as this helps to clear congestion. Urinary tract Infections (UTI) are common among women and the drug is effective in treating bacterial disease. Pneumonia, Bronchitis, and Gonorrhoea is also treated with amoxicillin and which targets the bacteria.
On the basis of the route Of Administration, the market is segmented into Oral and Intravenous. The oral route is considered convenient and easy . This route is regarded as effective for bacterial infections. The intravenous route is used in serious infections.
On the basis of form, the market is divided into Tablets, capsules, Suspensions, Syrup, and Powder. Tablets and capsules are consumed orally. It is prescribed according to the patient's age and weight. Suspension, Syrup, and powder are different forms that are available for children and adults who can’t swallow tablets.
According to Ravi Bhandari, Research Head, 6Wresearch on basis Of distribution channels, the market is segmented into Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The largest channel for the distribution is Hospital pharmacies as the demand is high for antibiotics. Retail pharmacies are easily accessible to the public . Online pharmacy's growth has accelerated in recent years. Other distribution channels are special pharmacies and government health agencies.
The report offers a comprehensive study of the subsequent market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 North America Amoxicillin Market Overview |
| 3.1 North America Amoxicillin Market Revenues & Volume, 2017 - 2027F |
| 3.2 North America Amoxicillin Market - Industry Life Cycle |
| 3.3 North America Amoxicillin Market - Porter's Five Forces |
| 3.4 North America Amoxicillin Market Revenues & Volume Share, By Countries, 2020 & 2027F |
| 3.5 North America Amoxicillin Market Revenues & Volume Share, By Infection Type, 2020 & 2027F |
| 3.6 North America Amoxicillin Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
| 3.7 North America Amoxicillin Market Revenues & Volume Share, By Form, 2020 & 2027F |
| 3.8 North America Amoxicillin Market Revenues & Volume Share, By Distribution Channel, 2020 & 2027F |
| 4 Impact Analysis of COVID-19 on North America Amoxicillin Market |
| 5 North America Amoxicillin Market Dynamics |
| 5.1 Impact Analysis |
| 5.2 Market Drivers |
| 5.3 Market Restraints |
| 6 North America Amoxicillin Market Trends |
| 7 North America Amoxicillin Market, 2017 - 2027 |
| 7.1 North America Amoxicillin Market, Revenues & Volume, By Infection Type, 2017 - 2027 |
| 7.2 North America Amoxicillin Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
| 7.3 North America Amoxicillin Market, Revenues & Volume, By Form, 2017 - 2027 |
| 7.4 North America Amoxicillin Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
| 8 United States Amoxicillin Market, 2017 - 2027 |
| 8.1 United States Amoxicillin Market, Revenues & Volume, By Infection Type, 2017 - 2027 |
| 8.2 United States Amoxicillin Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
| 8.3 United States Amoxicillin Market, Revenues & Volume, By Form, 2017 - 2027 |
| 8.4 United States Amoxicillin Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
| 9 Canada Amoxicillin Market, 2017 - 2027 |
| 9.1 Canada Amoxicillin Market, Revenues & Volume, By Infection Type, 2017 - 2027 |
| 9.2 Canada Amoxicillin Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
| 9.3 Canada Amoxicillin Market, Revenues & Volume, By Form, 2017 - 2027 |
| 9.4 Canada Amoxicillin Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
| 10 North America Amoxicillin Market Key Performance Indicators |
| 11 North America Amoxicillin Market - Opportunity Assessment |
| 11.1 North America Amoxicillin Market Opportunity Assessment, By Countries, 2027F |
| 11.2 North America Amoxicillin Market Opportunity Assessment, By Infection Type, 2027F |
| 11.3 North America Amoxicillin Market Opportunity Assessment, By Route of Administration, 2027F |
| 11.4 North America Amoxicillin Market Opportunity Assessment, By Form, 2027F |
| 11.5 North America Amoxicillin Market Opportunity Assessment, By Distribution Channel, 2027F |
| 12 North America Amoxicillin Market - Competitive Landscape |
| 12.1 North America Amoxicillin Market Revenue Share, By Companies, 2020 |
| 12.2 North America Amoxicillin Market Competitive Benchmarking, By Operating and Technical Parameters |
| 13 Company Profiles |
| 14 Recommendations |
| 15 Disclaimer |